Immune Deconvolution

Reference signatures act as comparison patterns for candidate cell populations. Immune deconvolution evaluates how the molecular signals observed in a bulk sample correspond to those patterns, then estimates each population’s relative contribution. This comparison is important because the measured profile combines signals from multiple cells, allowing researchers to interpret cellular composition without directly measuring every population separately.

A bulk profile represents a combined signal rather than an isolated measurement from one cell type. Deconvolution addresses this mixture by separating contributions computationally, producing relative rather than direct cell measurements. That distinction matters when comparing tumor samples, because the result describes estimated composition within complex tissue and helps distinguish immune components that contribute to the overall molecular profile.

Immune deconvolution complements single-cell and spatial profiling by providing a computational way to study complex tissue profiles from bulk measurements. Single-cell and spatial methods offer different types of detailed profiling, whereas deconvolution interprets aggregate molecular signals. Using these approaches as complements can broaden characterization of the tumor microenvironment and connect bulk analyses with more specialized measurements.

A basic workflow uses a bulk gene-expression or other molecular profile from a mixed sample, compares its observed signals with reference signatures, and reports estimated relative abundances of immune populations. In cancer research, the resulting profile can include infiltrating lymphocytes, myeloid cells, and other immune components, providing a computational summary of the sample’s tumor microenvironment.

Researchers can use the estimates to characterize variation in the tumor microenvironment across samples or patient groups. The resulting immune-cell profiles support patient stratification, treatment-response studies, and biomarker research. Because the output represents relative abundance estimates, it is useful for comparing immune composition in complex specimens rather than treating bulk molecular measurements as direct cell counts.

In cancer research, the method connects molecular measurements from tumor biopsies with questions about tumor immunity. Estimated levels of infiltrating lymphocytes, myeloid cells, and other immune components can support analyses of how the microenvironment relates to treatment response or patient grouping. It also provides a practical complement to single-cell and spatial profiling methods.